Author

Sandra Lovell

LOW INCIDENCE OF HYPERBILIRUBINAEMIA EVENTS WITH ABT-450/R/OMBITASVIR AND DASABUVIR WITH OR WITHOUT RIBAVIRIN IN HCV GENOTYPE-1 INFECTED PATIENTS

Manuel Romero-Gomez, Rui Tato Marinho, Ramon Vila, David E. Bernstein, Federico Rodriguez-Perez, Tarek Hassanein, K. Reddy, Naoky Tsai, Sandra Lovell, Jeffrey Enejosa, Yan Luo, Daniel E. Cohen, Marcos Pedrosa, Massimo Colombo

NORMALIZATION OF LIVER-RELATED LABORATORY PARAMETERS IN HCV GENOTYPE 1-INFECTED PATIENTS WITH CIRRHOSIS AFTER TREATMENT WITH ABT-450/R/OMBITASVIR, DASABUVIR AND RIBAVIRIN

Stefan Zeuzem, Stanislas Pol, Marc Bourlière, Angeles Castro, Marina Berenguer, Sam Lee, Gregory Everson, Sandra Lovell, Marcos Pedrosa, Roger Trinh

SAFETY COMPARISON OF 12- AND 24-WEEK TREATMENTS IN HCV GENOTYPE 1-INFECTED PATIENTS WITH CIRRHOSIS: RESULTS FROM TURQUOISE-II

Heiner Wedemeyer, Xavier Forns, Antonio Craxi, Paul Kwo, Stefan Bourgeois, Michael Bennett, Stephen Ryder, Dominique Larrey, David Mutimer, Sandra Lovell, Manal Abunimeh, Marcos Pedrosa, Roger Trinh

Item 1 - 3 / 3
1